Gerhard Seipke

1.0k total citations
22 papers, 719 citations indexed

About

Gerhard Seipke is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gerhard Seipke has authored 22 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Surgery and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gerhard Seipke's work include Metabolism, Diabetes, and Cancer (9 papers), Pancreatic function and diabetes (9 papers) and DNA and Nucleic Acid Chemistry (5 papers). Gerhard Seipke is often cited by papers focused on Metabolism, Diabetes, and Cancer (9 papers), Pancreatic function and diabetes (9 papers) and DNA and Nucleic Acid Chemistry (5 papers). Gerhard Seipke collaborates with scholars based in Germany, United States and Australia. Gerhard Seipke's co-authors include Jürgen Eckel, Hans‐Adolf Arfmann, Karl Wagner, Thomas Kolter, Irini Rakatzi, Rolf Hilgenfeld, Harald Berchtold, David R. Owens, L. Carter and Monika Kellerer and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Gerhard Seipke

22 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerhard Seipke Germany 13 461 399 349 118 50 22 719
L. Snel Denmark 6 220 0.5× 295 0.7× 195 0.6× 80 0.7× 18 0.4× 7 528
S Ganguly United States 6 65 0.1× 453 1.1× 110 0.3× 59 0.5× 31 0.6× 8 593
Bruno Hansen Denmark 13 105 0.2× 252 0.6× 128 0.4× 66 0.6× 26 0.5× 19 444
Gillian M. Danielsen Denmark 9 163 0.4× 314 0.8× 147 0.4× 40 0.3× 42 0.8× 10 436
Olov Wålinder Sweden 12 100 0.2× 296 0.7× 33 0.1× 51 0.4× 90 1.8× 30 518
K Shida Japan 14 273 0.6× 156 0.4× 37 0.1× 102 0.9× 43 0.9× 70 606
Kasturi Mukherjee India 9 33 0.1× 126 0.3× 76 0.2× 43 0.4× 37 0.7× 18 340
Glen Teshima United States 9 100 0.2× 362 0.9× 31 0.1× 39 0.3× 48 1.0× 11 556
Thomas W. Strickland United States 12 102 0.2× 259 0.6× 16 0.0× 64 0.5× 28 0.6× 16 560
Alexander N. Zaykov United States 11 94 0.2× 288 0.7× 107 0.3× 39 0.3× 70 1.4× 18 500

Countries citing papers authored by Gerhard Seipke

Since Specialization
Citations

This map shows the geographic impact of Gerhard Seipke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Seipke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Seipke more than expected).

Fields of papers citing papers by Gerhard Seipke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard Seipke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Seipke. The network helps show where Gerhard Seipke may publish in the future.

Co-authorship network of co-authors of Gerhard Seipke

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Seipke. A scholar is included among the top collaborators of Gerhard Seipke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Seipke. Gerhard Seipke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sandow, J., et al.. (2015). Equivalent Recombinant Human Insulin Preparations and their Place in Therapy. touchREVIEWS in Endocrinology. 11(1). 10–10. 21 indexed citations
2.
Hilgenfeld, Rolf, Gerhard Seipke, Harald Berchtold, & David R. Owens. (2014). The Evolution of Insulin Glargine and its Continuing Contribution to Diabetes Care. Drugs. 74(8). 911–927. 70 indexed citations
3.
Sommerfeld, Mark, Günter Müller, Georg Tschank, et al.. (2010). In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites. PLoS ONE. 5(3). e9540–e9540. 111 indexed citations
4.
Discher, Thomas, et al.. (2008). Rezidivierende Hypoglykämien bei Insulin-Autoimmunsyndrom. DMW - Deutsche Medizinische Wochenschrift. 115(51/52). 1950–1955. 2 indexed citations
5.
Seipke, Gerhard, et al.. (2006). Insulin Glulisine—A Comprehensive Preclinical Evaluation. International Journal of Toxicology. 25(1). 25–33. 31 indexed citations
6.
Hennige, Anita M., et al.. (2005). Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors. Diabetologia. 48(9). 1891–1897. 22 indexed citations
7.
Rakatzi, Irini, Gerhard Seipke, & Jürgen Eckel. (2003). [LysB3, GluB29] insulin: a novel insulin analog with enhanced β-cell protective action. Biochemical and Biophysical Research Communications. 310(3). 852–859. 36 indexed citations
8.
Rakatzi, Irini, et al.. (2003). A Novel Insulin Analog With Unique Properties. Diabetes. 52(9). 2227–2238. 47 indexed citations
9.
Ciaraldi, Theodore P., L. Carter, Gerhard Seipke, Sunder Mudaliar, & Robert R. Henry. (2001). Effects of the Long-Acting Insulin Analog Insulin Glargine on Cultured Human Skeletal Muscle Cells: Comparisons to Insulin and IGF-I. The Journal of Clinical Endocrinology & Metabolism. 86(12). 5838–5847. 84 indexed citations
10.
Kellerer, Monika, et al.. (1998). The Long Acting Human Insulin Analog HOE 901: Characteristics of Insulin Signalling in Comparison to Asp(B10) and Regular Insulin. Hormone and Metabolic Research. 30(3). 123–129. 81 indexed citations
11.
Kolter, Thomas, et al.. (1997). Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells. European Journal of Pharmacology. 320(2-3). 259–265. 92 indexed citations
12.
Seipke, Gerhard. (1991). Book Review: Protein Purification. Principles, High Resolution Methods and Applications. Edited by J.‐C. Janson and L. Rydén. Angewandte Chemie International Edition in English. 30(2). 212–213. 4 indexed citations
13.
Wildey, Gary, Alan J. Fischman, John T. Fallon, et al.. (1988). Cellular Processing of Pro-Atrial Natriuretic Factor (Pro-ANF): Studies Using an Antiserum that Selectively Binds ANF-(99–126) after Its Cleavage from Pro-ANF*. Endocrinology. 123(4). 2054–2061. 6 indexed citations
14.
Bloch, Kenneth D., Steven W. Jones, G. Preibisch, et al.. (1987). Proatrial natriuretic factor is phosphorylated by rat cardiocytes in culture.. Journal of Biological Chemistry. 262(21). 9956–9961. 16 indexed citations
15.
Seipke, Gerhard, et al.. (1986). High‐Pressure Liquid Chromatography (HPLC) of Proteins [New Analytical Methods (29)]. Angewandte Chemie International Edition in English. 25(6). 535–552. 12 indexed citations
16.
Seipke, Gerhard, et al.. (1986). Hochdruckflüssigkeitschromatographie (HPLC) von Proteinen. Angewandte Chemie. 98(6). 530–548. 7 indexed citations
17.
Seipke, Gerhard, Hans‐Adolf Arfmann, & Karl Wagner. (1980). Conformation of sequential and random lysine–phenylalanine copolypeptides. Biopolymers. 19(1). 189–201. 6 indexed citations
18.
Seipke, Gerhard, Hans‐Adolf Arfmann, & Karl Wagner. (1979). Specificity of DNA–basic polypeptide interactions. III. Sequential and random copolymers of lysine and aromatic amino acids. Biopolymers. 18(4). 855–872. 10 indexed citations
19.
Arfmann, Hans‐Adolf, et al.. (1977). Specificity of DNA-basic polypeptide interactions. 11. Influence of aromatic amino acid residues investigated with agarose bound lysine copolypeptides. Nucleic Acids Research. 4(3). 513–522. 7 indexed citations
20.
Seipke, Gerhard, Hans‐Adolf Arfmann, & Karl Wagner. (1974). Synthesis and properties of alternating poly(Lys‐Phe) and comparison with the random copolymer poly(Lys51, Phe49). Biopolymers. 13(8). 1621–1633. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Snel Breakdown of academic impact, for papers by S Ganguly Breakdown of academic impact, for papers by Bruno Hansen Breakdown of academic impact, for papers by Gillian M. Danielsen Breakdown of academic impact, for papers by Olov Wålinder Breakdown of academic impact, for papers by K Shida Breakdown of academic impact, for papers by Kasturi Mukherjee Breakdown of academic impact, for papers by Glen Teshima Breakdown of academic impact, for papers by Thomas W. Strickland Breakdown of academic impact, for papers by Alexander N. Zaykov
Rankless by CCL
2026